Location History:
- Lake Bluff, IL (US) (1992 - 1993)
- Gurnee, IL (US) (1994)
- Santa Ana, CA (US) (1991 - 1995)
- San Diego, CA (US) (1993 - 2003)
- Encinitas, CA (US) (1998 - 2009)
Company Filing History:
18 out of 2,285 
14 out of 37 
3 out of 3 
Years Active: 1991-2009
Title: Ming Fai Chan: Innovating Therapeutics through Patented Technology
Introduction
Ming Fai Chan, a prominent inventor based in San Diego, CA, has made significant contributions to the field of therapeutic compounds. With a remarkable portfolio of 39 patents, Chan’s work focuses on innovations that target complex diseases, prominently cancer. His inventions have the potential to revolutionize treatment modalities and make lasting impacts on patient care.
Latest Patents
Among his latest innovations, Chan has developed two notable patents:
1. **Enzyme Catalyzed Therapeutic Compounds** - This invention introduces novel compounds derived from a 1,5-substituted pyrimidine derivative or its analogs, including substituted furano-pyrimidone analogs. These compounds are designed to effectively treat or prevent diseases, particularly cancer.
2. **Enzyme Catalyzed Therapeutic Activation** - This invention details novel substrate compounds that uniquely inhibit the proliferation of pathological cells. The enzyme involved facilitates the conversion of the substrate into a cellular toxin or releases a toxic byproduct, thus targeting cells that overexpress a specific enzyme, which often confers resistance to traditional therapies. This method also includes the use of prodrugs that can be combined with other chemotherapy or radiation therapies.
Career Highlights
Throughout his career, Ming Fai Chan has associated with leading firms in the biotechnology industry. Notable companies he has worked with include Allergan, Inc. and Texas Biotechnology Corporation. His professional journey reflects his commitment to advancing medical science through innovative research and development.
Collaborations
In his pursuit of innovation, Chan has collaborated with skilled professionals in the field. Noteworthy coworkers include Vitukudi Narayanaiyengar Balaji and Adam Kois, with whom he has shared ideas and developed groundbreaking therapeutic solutions.
Conclusion
Ming Fai Chan stands out as a trailblazer in the area of therapeutic innovations. His 39 patents, particularly in enzyme-catalyzed compounds and activation processes, underscore his role as a vital contributor to the medical and research community. The applications of his inventions hold promise for enhancing treatment options for diseases like cancer, thereby improving patient outcomes.